NEUROGESX INC. - and - ASTELLAS PHARMA EUROPE LIMITED DISTRIBUTION, MARKETING AND LICENSE AGREEMENT ConfidentialCommercial Supply and License Agreement • July 1st, 2009 • NeurogesX Inc • Pharmaceutical preparations
This DISTRIBUTION, MARKETING AND LICENSE Agreement (hereinafter “Agreement”), made as of the 19th day of June, 2009 (“Effective Date”), between NeurogesX Inc., a Delaware corporation having a place of business at 2215 Bridgepointe Parkway, Suite 200, San Mateo, California 94404, United States of America (“NGX”) and Astellas Pharma Europe Ltd, a corporation established under the laws of England and Wales having a place of business at Lovett House, Lovett Road, Staines, Middlesex, TW18 3AZ, United Kingdom (“Astellas”). Each of NGX and Astellas shall be a “Party,” and together the “Parties.”
COMMERCIAL SUPPLY AND LICENSE AGREEMENTCommercial Supply and License Agreement • November 14th, 2013 • Nupathe Inc. • Pharmaceutical preparations • New Jersey
This COMMERCIAL MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”), is entered into as of 9th day of October, 2013 (“Effective Date”) by and between, NuPathe Inc., a Delaware corporation with its principal place of business at 7 Great Valley Parkway, Malvern, PA 19355 USA (“NuPathe”) and LTS Lohmann Therapy Systems Corp, a corporation with its principal place of business at 21 Henderson Drive, West Caldwell, NJ 07006 (“LTS”). Each of NuPathe and LTS shall be a “Party,” and together shall be referred to as the “Parties.”
